What are the differences between endovascular aneurysm repair (EVAR) and open surgical repair for abdominal aortic aneurysm (AAA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

EVAR vs Open Surgery for AAA: Key Differences

For patients with suitable anatomy and reasonable life expectancy (>2 years), EVAR should be considered the preferred therapy for elective AAA repair, while open repair remains the gold standard for young, healthy patients with long life expectancy and those with connective tissue disorders. 1

Perioperative Mortality & Morbidity

EVAR demonstrates dramatically superior short-term outcomes:

  • Perioperative mortality: EVAR <1% vs Open repair 5-10% 1
  • 30-day mortality: EVAR significantly lower (OR 0.36) 2
  • Cardiovascular complications: EVAR has substantially fewer peri-operative CV events (death, MI, stroke) 1

The early survival advantage of EVAR is most pronounced in the first 6 months, with significantly lower hazard of all-cause death (HR 0.62) and aneurysm-related death (HR 0.42) during this period 2.

Long-Term Outcomes: The Critical Reversal

The initial EVAR advantage disappears over time, with outcomes favoring open repair after 4-8 years:

  • Long-term mortality: No difference in all-cause mortality at any time point (HR 1.02) 2
  • Aneurysm-related mortality after 8 years: Significantly HIGHER with EVAR (HR 5.12) 2
  • 10-year survival: Better with open repair 1

This reversal occurs due to late EVAR-specific complications including fatal endograft ruptures, endoleaks, and device migration 1, 2.

Reintervention Requirements

EVAR carries a substantially higher reintervention burden:

  • Secondary interventions: 2.13 times higher risk with EVAR 2
  • Aneurysm rupture risk: 5-fold higher after EVAR (OR 5.08) 2
  • Death due to rupture: 3.57 times higher with EVAR 2
  • Crude reintervention rate: 16% EVAR vs 2.4% open repair 3

Surveillance Requirements

EVAR mandates lifelong surveillance due to risk of endoleaks (occurring in up to one-third of patients), graft migration, and late rupture 1. This includes:

  • CCT or duplex ultrasound at 6-12 months
  • Annual surveillance for first 5 years
  • Every 5 years thereafter if stable 1

Open repair requires minimal long-term surveillance after initial recovery.

Perioperative Recovery & Hospital Stay

EVAR offers substantial short-term advantages:

  • Percutaneous femoral approach allows local anesthesia 1
  • Significantly shorter hospital stays 4
  • Lower transfusion requirements 4
  • Faster return to normal activities 5
  • Lower need for mechanical ventilation and ICU stay 5

Open repair involves:

  • Mid-line laparotomy with notable morbidity 1
  • Complication rate ~48% in ruptured cases 1
  • Increased incisional hernia risk, especially in obese patients 1
  • Longer recovery period

Cost Considerations

Open repair is significantly less expensive ($12,879 vs $18,058 USD), despite EVAR's shorter hospital stay 4. The higher EVAR costs stem from:

  • Expensive endovascular devices
  • Mandatory lifelong surveillance imaging
  • Higher reintervention rates over time 6

Specific Clinical Scenarios

Ruptured AAA

EVAR is recommended over open repair (Class I, Level B) to reduce peri-operative morbidity and mortality in patients with suitable anatomy 1.

Connective Tissue Disorders

Open repair is mandatory for patients with Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syndrome (Class I, Level C) 7. EVAR is contraindicated due to progressive aortic disease.

Young, Healthy Patients

Open repair is advisable for patients with life expectancy >10 years, given superior long-term durability and freedom from reintervention 1, 3.

Limited Life Expectancy (<2 years)

Elective AAA repair is not recommended regardless of technique (Class III, Level B) 1.

Complex Anatomy (Juxta-renal/Para-renal)

Both approaches can be offered in high-volume centers with similar outcomes. Fenestrated or branched endografts should be considered for complex endovascular treatment 1.

Critical Pitfalls

  • Assuming EVAR's early benefit persists long-term: The mortality advantage reverses after 4-8 years
  • Inadequate patient counseling about surveillance: Patients must understand EVAR requires lifelong monitoring
  • Ignoring anatomic suitability: Only 60-70% of infrarenal AAAs are suitable for EVAR 1
  • Overlooking life expectancy: EVAR's benefits diminish in patients expected to live >10 years
  • Chronic anticoagulation: Constitutes a risk factor for endoleak-related complications, reintervention, and mortality 1

References

2
Research

Editor's Choice - Endovascular vs. Open Repair for Abdominal Aortic Aneurysm: Systematic Review and Meta-analysis of Updated Peri-operative and Long Term Data of Randomised Controlled Trials.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2020

6
Research

Endovascular versus open repair of abdominal aortic aneurysm.

The New England journal of medicine, 2010

Related Questions

What is an abdominal aortic aneurysm and why does it occur?
What patient education should be given for a 5.2 cm abdominal aortic aneurysm (AAA) diagnosed by ultrasound?
Is a pulsating sensation in the abdomen without other symptoms a sign of an abdominal aortic aneurysm that requires urgent evaluation?
In a 76-year-old man with an incidental abdominal aortic aneurysm measuring 43 mm on CT, what is the recommended management and surveillance?
Can abdominal aortic aneurysms (AAA) cause leg swelling?
Under which medical specialty is sebaceous cyst removal performed?
What is the underlying mechanism of the 6 H’s syndrome (elevated fibroblast growth factor‑23, hypophosphatemia, hyperphosphaturia, hypocalcemia, secondary hyperparathyroidism) that occurs after administration of Ferinject (ferric carboxymaltose)?
What bacterial organisms are covered by levofloxacin?
Can betamethasone cream be used to treat the symptoms of insect bites?
What is the recommended antibiotic regimen for salpingo‑oophoritis?
Can a beta‑1‑selective blocker such as bisoprolol be used in a patient with triple‑vessel coronary disease and critical limb ischemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.